Whether you’re an alumnus, current student, member of the faculty and staff, donor, or neighbor, you’re a valuable part of the CU Denver community. Help us celebrate the last 50 years and a future that works for all.
This talk will describe the types of early communications with the FDA and the high level requirements for nonclinical programs supporting clinical development of 4 product types: small molecules, protein therapeutics, prophylactic vaccines and cell and gene therapies. Case studies will be provided.
Speaker: Melanie Hartsough, Independent Consultant at Hartsough Nonclinical Consulting, LLC